The DOI matches its Crossref record; 424 of the 424 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 424
Complement fragments C3a and C5a: The salt and pepper of the immune response
Sacks, S. H. (2010) · European Journal of Immunology · doi:10.1002/eji.201040355 · Cited by 83
Ruan, B. H., Li, X., Winkler, A. R., Cunningham, K. M., Kuai, J., Greco, R. M., Nocka, K. H., Fitz, L. J., Wright, J. F., Pittman, D. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000863 · Cited by 83
Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann, M., & Götze, O. (1994) · PubMed · Cited by 83
The active site of C3a anaphylatoxin.
Caporale, L. H., Tippett, P. S., Erickson, B. W., & Hugli, T. E. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70372-x · Cited by 82
Dobrina, A., Pausa, M., Fabio Fischetti, I., Bulla, R., Vecile, E., Ferrero, E., Mantovani, A., & Tedesco, F. (2002) · Blood · doi:10.1182/blood.v99.1.185 · Cited by 82
Preservation of Antimicrobial Properties of Complement Peptide C3a, from Invertebrates to Humans
Pasupuleti, M., Walse, B., Nordahl, E. A., Mörgelin, M., Malmsten, M., & Schmidtchen, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607848200 · Cited by 82
Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes
Sayah, S., Jauneau, A.-C., Patte‐Mensah, C., Tonon, M., Vaudry, H., & Fontaine, M. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00046-9 · Cited by 82
Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival
Lewis, A. G., Köhl, G., Ma, Q., Devarajan, P., & Köhl, J. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03678.x · Cited by 81
Gerard, N. P., Lu, B., He, X. P., Eddy, R. L., Shows, T. B., & Gerard, C. J. (1993) · Biochemistry · doi:10.1021/bi00056a007 · Cited by 81
Changes in the Novel Orphan, C5a Receptor (C5L2), during Experimental Sepsis and Sepsis in Humans
Huber-Lang, M. S., Sarma, J. V., Rittirsch, D., Schreiber, H. A., Weiss, M., Flierl, M. A., Younkin, E. M., Schneider, M., Suger-Wiedeck, H., Gebhard, F. T., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1104 · Cited by 80
Self-citationPlasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis
Song, J. J., Hwang, I., Cho, K. H., Garcia, M. A., Kim, A. J., Wang, T. H., Lindström, T. M., Lee, A. T., Nishimura, T., Zhao, L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46387 · Cited by 80
CiC3-1a-Mediated Chemotaxis in the Deuterostome Invertebrate Ciona intestinalis (Urochordata)
Pinto, M. R., Chinnici, C. M., Kimura, Y., Melillo, D., Marino, R., Spruce, L. A., Santis, R. D., Parrinello, N., & Lambris, J. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5521 · Cited by 80
C3a Receptor Antagonist Attenuates Brain Injury after Intracerebral Hemorrhage
Rynkowski, M. A., Kim, G. H., Garrett, M. C., Zacharia, B. E., Otten, M. L., Sosunov, S. A., Komotar, R. J., Hassid, B. G., Ducruet, A. F., Lambris, J. D., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.95 · Cited by 80
Zhang, X., Boyar, W. C., Toth, M. J., Wennogle, L. P., & Gonnella, N. C. (1997) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(199706)28:2<261::aid-prot13>3.0.co;2-g · Cited by 79
Ignatius, A. A., Ehrnthaller, C., Brenner, R. E., Kreja, L., Schoengraf, P., Lisson, P., Blakytny, R., Recknagel, S., Claes, L., Gebhard, F., et al. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181f8aa2d · Cited by 79
Murray, I. V. J., Sniderman, A. D., Havel, P. J., & Cianflone, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36219 · Cited by 79
Postma, B., Kleibeuker, W., Poppelier, M. J. J. G., Boonstra, M., van Kessel, K. P. M., van Strijp, J. A. G., & de Haas, C. J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412230200 · Cited by 79
Tsuboi, N., Ernandez, T., Li, X., Nishi, H., Culleré, X., Mekala, D. J., Hazen, M. M., Köhl, J., Lee, D. M., & Mayadas, T. N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30141 · Cited by 78
An Activation Switch in the Ligand Binding Pocket of the C5a Receptor
Gerber, B. O., Meng, E. C., Dötsch, V., Baranski, T., & Bourne, H. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007748200 · Cited by 78
G protein‐coupled receptors: the inside story
Jalink, K., & Moolenaar, W. H. (2009) · BioEssays · doi:10.1002/bies.200900153 · Cited by 78
Raby, A., Holst, B., Davies, J. A., Colmont, C. S., Laumonnier, Y., Coles, B., Shah, S., Hall, J. E., Topley, N., Köhl, J., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201041350 · Cited by 78
Paglialunga, S., Schrauwen, P., Roy, C., Moonen‐Kornips, E., Lü, H., Hesselink, M. K. C., Deshaies, Y., Richard, D., & Cianflone, K. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0205 · Cited by 78
Designing synthetic superagonists of C3a anaphylatoxin
Ember, J. A., Johansen, N. L., & Hugli, T. E. (1991) · Biochemistry · doi:10.1021/bi00229a003 · Cited by 77
Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI)
Leung, L. L. K., Myles, T., Nishimura, T., et al. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.010 · Cited by 77
LU, Z. X., Fok, K. F., Erickson, B. W., & Hugli, T. E. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42796-7 · Cited by 76
Biologic activity of synthetic analogues of C5a anaphylatoxin
Ember, J. A., Sanderson, S. D., Taylor, S. M., Kawahara, M., & Hugli, T. E. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.10.3165 · Cited by 76
Mery, L., & Boulay, F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41884-9 · Cited by 75
Xia, Z., Stanhope, K. L., Digitale, E., Simion, O.-M., Chen, L., Havel, P. J., & Cianflone, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311319200 · Cited by 75
Chronological changes in the complement system in sepsis
Nakae, H., Endo, S., Inada, K., & Yoshida, M. (1996) · Surgery Today · doi:10.1007/bf00311579 · Cited by 75
Takematsu, H., OHKOHCHI, K., & Tagami, H. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb02773.x · Cited by 75
Adipokines and the Immune System: An Adipocentric View
MacLaren, R., Cui, W., & Cianflone, K. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_1 · Cited by 74
Braun, L., Christophe, T., & Boulay, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210120200 · Cited by 74
Adiponectin binds C1q and activates the classical pathway of complement
Peake, P. W., Shen, Y., Walther, A., & CHARLESWORTH, J. A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.161 · Cited by 74
Maslowska, M., Wang, H., & Cianflone, K. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)70010-8 · Cited by 73
Rúa‐Figueroa, Í., Arencibia‐Mireles, O., Elvira, M. U. R., Erausquin, C., Ojeda, S., Francisco, F., Naranjo, A., Rodríguez‐Gallego, C., García-Laorden, I., Rodríguez-Perez, J., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.104349 · Cited by 73
Kanse, S. M., Gallenmueller, A., Zeerleder, S. S., Stephan, F., Rannou, O., Denk, S., Etscheid, M., Lochnit, G., Krüger, M., & Huber-Lang, M. S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103029 · Cited by 73
Familial aggregation and early expression of hyperapobetalipoproteinemia
Sniderman, A. D., Teng, B., Genest, J. J., Cianflone, K., Wacholder, S., & Kwiterovich, P. O. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90363-7 · Cited by 73
Pasupuleti, M., Walse, B., Svensson, B. R., Malmsten, M., & Schmidtchen, A. (2008) · Biochemistry · doi:10.1021/bi800991e · Cited by 72
Huynh, J., Thomas, W. G., Aguilar, M., & Pattenden, L. K. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.01.002 · Cited by 72
Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum
Bénard, M., Raoult, É., Vaudry, D., Leprince, J., Falluel‐Morel, A., Gonzalez, B. J., Galas, L., Vaudry, H., & Fontaine, M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.027 · Cited by 72
C5a Mutants Are Potent Antagonists of the C5a Receptor (CD88) and of C5L2
Otto, M., Hawlisch, H., Monk, P. N., Müller, M., Klos, A., Karp, C. L., & Köhl, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310078200 · Cited by 72
Self-citationJalili, A., Shirvaikar, N., Marquez‐Curtis, L. A., Qiu, Y., Korol, C., Lee, H., Turner, A. R., Ratajczak, M. Z., & Janowska‐Wieczorek, A. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.02.002 · Cited by 72
Naik, N. R., Giannini, E., Brouchon, L., & Boulay, F. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.19.2381 · Cited by 72
Wu, Y., Zhang, J., Wen, Y., Wang, H., Zhang, M., & Cianflone, K. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.031 · Cited by 71
Gerard, C. J., Chenoweth, D. E., & Hugli, T. E. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.5.1978 · Cited by 70
Siciliano, S. J., Rollins, T. E., & Springer, M. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45409-3 · Cited by 69
Complete primary structure of human C4a anaphylatoxin.
Moon, K. E., Gorski, J. P., & Hugli, T. E. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68898-8 · Cited by 69
Gavrilyuk, V., Kalinin, S., Hilbush, B. S., Middlecamp, A., McGuire, S. O., Pelligrino, D. A., Weinberg, G. L., & Feinstein, D. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02942.x · Cited by 69
Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance
Murray, I. V. J., Sniderman, A. D., & Cianflone, K. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33413-1 · Cited by 69
CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM‐B
Leick, M., Catusse, J., Follo, M., Nibbs, R. J. B., Hartmann, T. N., Veelken, H., & Burger, M. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03209.x · Cited by 68
Role of the Second Extracellular Loop of Human C3a Receptor in Agonist Binding and Receptor Function
Chao, T.-H., Ember, J. A., Wang, M., Bayón, Y., Hugli, T. E., & Ye, R. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9721 · Cited by 68
Zhang, X., Lewkowich, I. P., Köhl, G., Clark, J. R., Wills-Karp, M. A., & Köhl, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804276 · Cited by 68
Hollmann, T. J., Mueller‐Ortiz, S. L., Braun, M., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.037 · Cited by 67
Johswich, K. O., Martin, M., Thalmann, J., Rheinheimer, C., Monk, P. N., & Klos, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609734200 · Cited by 67
Self-citationOhta, R., Torii, Y., Imai, M., Kimura, H., Okada, N., & Ito, Y. (2011) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2011.00309.x · Cited by 65
C5a Receptor Targeting in Neointima Formation After Arterial Injury in Atherosclerosis-Prone Mice
Shagdarsuren, E., Bidzhekov, K., Mause, S. F., Simsekyilmaz, S., Polakowski, T., Hawlisch, H., Gessner, J. E., Zernecke, A., & Weber, C. (2010) · Circulation · doi:10.1161/circulationaha.110.954370 · Cited by 65
Mack, W. J., Ducruet, A. F., Hickman, Z. L., Garrett, M. C., Albert, E. J., Kellner, C. P., Mocco, J., & Connolly, E. S. (2007) · Neurosurgery · doi:10.1227/01.neu.0000255518.96837.8e · Cited by 64
Plasma Acylation-Stimulating Protein in Coronary Artery Disease
Cianflone, K., Zhang, X., Genest, J. J., & Sniderman, A. D. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvb.17v07.1239 · Cited by 63
Antifungal activity of C3a and C3a-derived peptides against Candida
Sonesson, A., Ringstad, L., Nordahl, E. A., Malmsten, M., Mörgelin, M., & Schmidtchen, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.10.017 · Cited by 63
Complement in neuroprotection and neurodegeneration
Yanamadala, V., & Friedlander, R. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.12.001 · Cited by 63
Francis, K. L., Lewis, B. M., Akatsu, H., Monk, P. N., Cain, S. A., Scanlon, M. F., Morgan, B. P., Ham, J., & Gasque, P. (2003) · The FASEB Journal · doi:10.1096/fj.02-1103fje · Cited by 63
Self-citationMachalińska, A., Dziedziejko, V., Mozolewska‐Piotrowska, K., Karczewicz, D., Wiszniewska, B., & Machaliński, B. (2009) · Ophthalmic Research · doi:10.1159/000219686 · Cited by 62
The Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand Binding
Scola, A.-M., Higginbottom, A., Partridge, L. J., Reid, R. C., Woodruff, T. M., Taylor, S. M., Fairlie, D. P., & Monk, P. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609178200 · Cited by 62
Self-citationResponse of plasma ASP to a prolonged fast.
Cianflone, K., Kalant, D., Eb, M., Gougeon, R., & Sniderman, A. D. (1995) · PubMed · Cited by 62
Regulation of C3a Receptor Signaling in Human Mast Cells by G Protein Coupled Receptor Kinases
Guo, Q., Subramanian, H., Gupta, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022559 · Cited by 60
Maher, S. G., McDowell, D. T., Collins, B. C., Muldoon, C., Gallagher, W. M., & Reynolds, J. V. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31823699f2 · Cited by 60
Structure-Function Relationships of Human C5a and C5aR
Huber-Lang, M. S., Sarma, J. V., McGuire, S. R., Lu, K. T., Padgaonkar, V. A., Younkin, E. M., Guo, R. F., Weber, C. H., Zuiderweg, E. R. P., Zetoune, F. S., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6115 · Cited by 60
堀野, 敬. (1998) · Medical Entomology and Zoology · doi:10.11501/3166022 · Cited by 60
Murray, I. V. J., Sniderman, A. D., & Cianflone, K. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.3.e474 · Cited by 60
Klco, J. M., Nikiforovich, G. V., & Baranski, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600548200 · Cited by 59
Identification and synthesis of a receptor binding site of human anaphylatoxin C5a
Kawai, M., Quincy, D. A., Lane, B. C., Mollison, K. W., Luly, J. R., & Carter, G. W. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00111a022 · Cited by 59
Complement Regulates CD4 T-Cell Help to CD8 T Cells Required for Murine Allograft Rejection
Vieyra, M. B., Leisman, S. A., Raedler, H., Kwan, W.-H., Yang, M., Strainic, M. G., Medof, M. E., & Heeger, P. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.038 · Cited by 59
C5a Regulates NKT and NK Cell Functions in Sepsis
Fusakio, M. E., Mohammed, J. P., Laumonnier, Y., Hoebe, K. H. N., Köhl, J., & Mattner, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100338 · Cited by 59
Tornetta, M. A., Foley, J. J., Sarau, H. M., & Ames, R. S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5277 · Cited by 58
Langkabel, P., Zwirner, J., & Oppermann, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<3035::aid-immu3035>3.0.co;2-z · Cited by 58
Deficiency of C5aR Prolongs Renal Allograft Survival
Li, Q., Peng, Q., Xing, G., Li, K., Wang, N., Farrar, C. A., Meader, L., Sacks, S. H., & Zhou, W. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009090977 · Cited by 58
Reis, E. S., Chen, H., Sfyroera, G., Monk, P. N., Köhl, J., Ricklin, D., & Lambris, J. D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200834 · Cited by 58
Self-citationInactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease
Oda, T., Kojima, Y., Akaike, T., Ijiri, S., Molla, A., & Maeda, H. (1990) · Infection and Immunity · doi:10.1128/iai.58.5.1269-1272.1990 · Cited by 58
Abdul‐Salam, V. B., Paul, G. A., Ali, J. O., Gibbs, S. R., Rahman, D., Taylor, G. W., Wilkins, M. R., & Edwards, R. J. (2006) · PROTEOMICS · doi:10.1002/pmic.200500510 · Cited by 57
Sulfation of Tyrosine 174 in the Human C3a Receptor Is Essential for Binding of C3a Anaphylatoxin
Gao, J., Choe, H., Bota, D., Wright, P. L., Gerard, C. J., & Gerard, N. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306061200 · Cited by 57
Nishimura, T., Horino, K., Nishiura, H., Shibuya, Y., Hiraoka, T., Tanase, S., & Yamamoto, T. (2001) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a002876 · Cited by 57
Strachan, A. J., Shiels, I. A., Reid, R. C., Fairlie, D. P., & Taylor, S. M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704417 · Cited by 56
Genetic Mapping of the Human C5a Receptor
Geva, A., Lassere, T. B., Lichtarge, O., Pollitt, S. K., & Baranski, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005602200 · Cited by 56
DiMartino, S. J., Shah, A. B., Trujillo, G., & Kew, R. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2688 · Cited by 55
Luo, Y., Zeng, Q., Glisson, J. R., Jackwood, M. W., Cheng, I.-H. N., & Wang, C. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00266-7 · Cited by 54
Higginbottom, A., Cain, S. A., Woodruff, T. M., Proctor, L. M., Madala, P. K., Tyndall, J. D. A., Taylor, S. M., Fairlie, D. P., & Monk, P. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410797200 · Cited by 54
Self-citationC3a(desArg) does not bind to and signal through the human C3a receptor
Wilken, H.-C., Götze, O., Werfel, T., & Zwirner, J. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00002-4 · Cited by 54
van Oostrom, A. J., van Dijk, H., Verseyden, C., Sniderman, A. D., Cianflone, K., Rabelink, T. J., & Castro Cabezas, M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.510 · Cited by 53
Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo
Nishimura, T., Myles, T., Piliposky, A. M., Kao, P. N., Berry, G. J., & Leung, L. L. K. (2006) · Blood · doi:10.1182/blood-2006-03-012567 · Cited by 53
Metabolic response of Acylation Stimulating Protein to an oral fat load.
Cianflone, K., Vu, H., Walsh, M. J., Baldo, A., & Sniderman, A. D. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38229-8 · Cited by 53
C5a-Stimulated Recruitment of β-Arrestin2 to the Nonsignaling 7-Transmembrane Decoy Receptor C5L2
van Lith, L. H. C. J., Oosterom, J., van Elsas, A., & Zaman, G. J. R. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109341407 · Cited by 53
Autoimmunity and tyrosine sulfation
Hsu, W., Rosenquist, G. L., Ansari, A. A., et al. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.03.004 · Cited by 52
Complement C3a Regulates Late Asthmatic Response and Airway Hyperresponsiveness in Mice
Mizutani, N., Nabe, T., & Yoshino, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901468 · Cited by 52
Ancient Origin of the Complement System: Emerging Invertebrate Models
Pinto, M. R., Melillo, D., Giacomelli, S., Sfyroera, G., & Lambris, J. D. (2007) · Springer eBooks · doi:10.1007/978-0-387-71767-8_26 · Cited by 50
Levels of acylation stimulating protein in obese women before and after moderate weight loss.
Sniderman, A. D., Cianflone, K., & Eckel, R. H. (1991) · PubMed · Cited by 50
Three-dimensional structure of porcine C5adesArg from proton nuclear magnetic resonance data
Williamson, M. P., & Madison, V. (1990) · Biochemistry · doi:10.1021/bi00464a002 · Cited by 50
C5L2 and C5aR interaction in adipocytes and macrophages: Insights into adipoimmunology
Poursharifi, P., Lapointe, M., Pétrin, D., Devost, D., Gauvreau, D., Hébert, T. E., & Cianflone, K. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.12.010 · Cited by 50
Veneskoski, M., Turunen, S. P., Kummu, O., Nissinen, A. E. T., Rannikko, S., Levonen, A., & Hörkkö, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.029 · Cited by 50
Inhibition of C5a receptor alleviates experimental CNS lupus
Jacob, A., Hack, B. K., Bai, T., Brorson, J. R., Quigg, R. J., & Alexander, J. J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.02.011 · Cited by 49
Honczarenko, M., Ratajczak, M. Z., Nicholson-Weller, A., & Silberstein, L. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3698 · Cited by 49
Koski, P., Rhen, M., Kantele, J. M., et al. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47253-0 · Cited by 48
Nettesheim, D. G., Edalji, R. P., Mollison, K. W., Greer, J., & Zuiderweg, E. R. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5036 · Cited by 48
High Levels of Complement C3a Receptor in the Glomeruli in Lupus Nephritis
Mizuno, M., Blanchin, S., Gasque, P., Nishikawa, K., & Matsuo, S. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.02.271 · Cited by 48
Nijs, J., Oosterwijck, J. V., Meeus, M., Lambrecht, L., Metzger, K., Frémont, M., & Paul, L. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02178.x · Cited by 47
Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury
Bao, L., Wang, Y., Haas, M., & Quigg, R. J. (2011) · Kidney International · doi:10.1038/ki.2011.158 · Cited by 47
Takahashi, M., Moriguchi, S., Suganuma, H., Shiota, A., Tani, F., Usui, H., Kurahashi, K., Sasaki, R., & Yoshikawa, M. (1997) · Peptides · doi:10.1016/s0196-9781(97)00044-2 · Cited by 47
Kanmura, S., Uto, H., Sato, Y., Kumagai, K., Sasaki, F., Moriuchi, A., Oketani, M., Ido, A., Nagata, K., Hayashi, K., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0160-5 · Cited by 46
Schnatbaum, K., Locardi, E., Scharn, D., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.036 · Cited by 45
C3a receptor deficiency accelerates the onset of renal injury in the MRL/lpr mouse
Wenderfer, S. E., Wang, H., Ke, B., Wetsel, R. A., & Braun, M. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.12.004 · Cited by 45
Tsuruta, T., Yamamoto, T., Matsubara, S., et al. (1993) · PubMed · Cited by 44
Busche, M. N., & Stahl, G. L. (2010) · PubMed · doi:10.3205/000109 · Cited by 44
C3aR inhibition reduces neurodegeneration in experimental lupus
Jacob, A., Bao, L., Brorson, J. R., Quigg, R. J., & Jj, A. (2009) · Lupus · doi:10.1177/0961203309348978 · Cited by 44
The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers
CHARLESWORTH, J. A., Peake, P. W., Campbell, L., Pussell, B., SO’Grady, & Tzilopoulos, T. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800733 · Cited by 44
Hartmann, T. N., Leick, M., Ewers, S., Diefenbacher, A., Schraufstätter, I. U., Honczarenko, M., & Burger, M. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02836.x · Cited by 43
Marcil, M., Vu, H., Cui, W., Dastani, Z., Engert, J. C., Gaudet, D., Cabezas, M. C., Sniderman, A. D., Genest, J. J., & Cianflone, K. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000222907.72985.0b · Cited by 42
Multiple Activation Steps of theN-Formyl Peptide Receptor
Prossnitz, E. R., Gilbert, T. L., Chiang, S. C., Campbell, J. J., Qin, S., Newman, W., Sklar, L. A., & Ye, R. D. (1999) · Biochemistry · doi:10.1021/bi982274t · Cited by 42
C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation
Cui, W., Simaan, M., Laporte, S. A., Lodge, R., & Cianflone, K. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.06.007 · Cited by 42
The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation
Krishnan, V., Xu, Y., Macon, K. J., et al. (2009) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909000389 · Cited by 42
Pals, J. V. D., Koul, S., Andersson, P., Götberg, M., Ubachs, J. F. A., Kanski, M., Arheden, H., Olivecrona, G., Larsson, B., & Erlinge, D. (2010) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-10-45 · Cited by 42
Ahamed, J., Haribabu, B., & Ali, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3559 · Cited by 42
Raffetseder, U., Röper, D., Mery, L., Gietz, C., Klos, A., Grötzinger, J., Wollmer, A., Boulay, F., Köhl, J., & Bautsch, W. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00082.x · Cited by 41
Self-citationWysoczynski, M., Kucia, M., Ratajczak, J., & Ratajczak, M. Z. (2007) · Leukemia · doi:10.1038/sj.leu.2404629 · Cited by 41
Sepsis-Induced Adipokine Change with regard to Insulin Resistance
Hillenbrand, A., Weiß, M., Knippschild, U., Wolf, A. M., & Huber-Lang, M. S. (2012) · International Journal of Inflammation · doi:10.1155/2012/972368 · Cited by 41
The Adipsin-ASP Pathway and Regulation of Adipocyte Function
Sniderman, A. D., & Cianflone, K. (1994) · Annals of Medicine · doi:10.3109/07853899409148358 · Cited by 41
Plasma C3 and C3a Levels in Cryptogenic and Large-Vessel Disease Stroke: Associations with Outcome
Stokowska, A., Olsson, S., Holmegaard, L., et al. (2011) · Cerebrovascular Diseases · doi:10.1159/000328238 · Cited by 41
Wetsel, R. A., Kildsgaard, J., Zsigmond, E. M., Liao, W., & Chan, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19429 · Cited by 40
Banda, N. K., Levitt, B., Wood, A., Takahashi, K., Stahl, G. L., Holers, V. M., & Arend, W. P. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04035.x · Cited by 40
Elevated plasma C4a levels in multiple sclerosis correlate with disease activity
Ingram, G., Hakobyan, S., Robertson, N. P., & Morgan, B. P. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.03.014 · Cited by 40
Helix 8 Plays a Crucial Role in Bradykinin B2 Receptor Trafficking and Signaling
Feierler, J., Wirth, M., Welte, B., Schüssler, S., Jochum, M., & Faußner, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256909 · Cited by 40
Development of C5a receptor antagonists.
Wong, A. K., Taylor, S. M., & Fairlie, D. P. (1999) · PubMed · Cited by 39
Complement anaphylatoxin C3a as a novel independent prognostic marker in heart failure
Gombos, T., Förhécz, Z., Pozsonyi, Z., Széplaki, G., Kunde, J., Füst, G., Jánoskuti, L., Karádi, I., & Prohászka, Z. (2012) · Clinical Research in Cardiology · doi:10.1007/s00392-012-0432-6 · Cited by 39
Sun, S., Guo, Y., Zhao, G., Zhou, X., Li, J., Hu, J., Yu, H., Chen, Y., Song, H., Qiao, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026838 · Cited by 39
Chimeric Receptors of the Human C3a Receptor and C5a Receptor (CD88)
Crass, T., Ames, R. S., Sarau, H. M., Tornetta, M. A., Foley, J. J., Köhl, J., Klos, A., & Bautsch, W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8367 · Cited by 39
Self-citationMonk, P. N., & Partridge, L. J. (1993) · Biochemical Journal · doi:10.1042/bj2950679 · Cited by 39
Self-citationCathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro
Huber-Lang, M. S., Denk, S., Fulda, S., Erler, E., Kalbitz, M., Weckbach, S., Schneider, E. M., Weiss, M., Kanse, S. M., & Perl, M. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2011.12.005 · Cited by 38
Complement Factor C5a in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Marc, M. M., Kristan, S. Š., Rozman, A., Kern, I., Fležar, M., Košnik, M., & Korošec, P. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02385.x · Cited by 38
The pharmacophore of the human C5a anaphylatoxin
Toth, M. J., Huwyler, L., Boyar, W. C., Braunwalder, A. F., Yarwood, D. R., Hadala, J. T., Haston, W. O., Sills, M. A., Seligmann, B. E., & Galakatos, N. G. (1994) · Protein Science · doi:10.1002/pro.5560030802 · Cited by 37
Xu, R., Wang, R., Han, G., Wang, J., Chen, G., Wang, L., Li, X., Guo, R., Shen, B., & Li, Y. (2010) · European Journal of Immunology · doi:10.1002/eji.200940015 · Cited by 37
Melillo, D., Sfyroera, G., Santis, R. D., Graziano, R., Marino, R., Lambris, J. D., & Pinto, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4132 · Cited by 36
Iyer, A., Woodruff, T. M., Wu, M. C. L., Stylianou, C., Reid, R. C., Fairlie, D. P., Taylor, S. M., & Brown, L. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31822a7a09 · Cited by 36
Revollo, I., Nishiura, H., Shibuya, Y., Oda, Y., Nishino, N., & Yamamoto, T. (2005) · Inflammation Research · doi:10.1007/s00011-004-1327-4 · Cited by 36
Matthan, N. R., Cianflone, K., Lichtenstein, A. H., Ausman, L. M., Jauhiainen, M., & Jones, P. J. H. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31510-8 · Cited by 36
Effect of the C3a-Receptor Antagonist SB 290157 on Anti-OVA Polyclonal Antibody–Induced Arthritis
Hutamekalin, P., Takeda, K., Tani, M., Tsuga, Y., Ogawa, N., Mizutani, N., & Yoshino, S. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09180fp · Cited by 35
Anaphylatoxin levels in human aqueous humor.
Mondino, B. J., Sidikaro, Y., & Sumner, H. L. (1986) · PubMed · Cited by 34
CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model
Ingersoll, S. A., Martin, C. B., Barnum, S. R., & Martin, B. K. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.08.007 · Cited by 33
Protective Role of Complement C5a in an Experimental Model of Staphylococcus aureus Bacteremia
von Köckritz‐Blickwede, M., Konrad, S., Foster, S. J., Gessner, J. E., & Medina, E. (2009) · Journal of Innate Immunity · doi:10.1159/000247157 · Cited by 33
Bock, D., Martin, U., Gärtner, S., Rheinheimer, C., Raffetseder, U., Arseniev, L., Barker, M. D., Monk, P. N., Bautsch, W., Köhl, J., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270631 · Cited by 33
Self-citationvan Wijngaarden, R. F. A. D. L., Cianflone, K., Gao, Y., Leunissen, R. W. J., & Hokken-Koelega, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0656 · Cited by 32
γδT-cell function in sepsis is modulated by C5a receptor signalling
Han, G., Geng, S., Li, Y., Chen, G., Wang, R., Li, X., Ma, Y., Shen, B., & Li, Y. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03445.x · Cited by 32
C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus
Wild, G., Watkins, J., Ward, A. M., Hughes, P. J., Hume, A., & Rowell, N. R. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb05227.x · Cited by 31
Brodbeck, R. M., Cortright, D. N., Kieltyka, A., Yu, J., Baltazar, C., Buck, M. E., Meade, R., Maynard, G. D., Thurkauf, A., Chien, D., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141572 · Cited by 30
Coupling of the C5a receptor to Gi in U-937 cells and in cells transfected with C5a receptor cDNA.
Vanek, M., Hawkins, L. D., & Gusovsky, F. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09822-0 · Cited by 30
Murray, I. V. J. (2000) · Endocrinology · doi:10.1210/en.141.3.1041 · Cited by 30
Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor.
Lienenklaus, S., Ames, R. S., Tornetta, M. A., Sarau, H. M., Foley, J. J., Crass, T., Sohns, B., Raffetseder, U., Grove, M., Hölzer, A., et al. (1998) · PubMed · Cited by 29
Self-citationComplement C3a Regulates Muc5ac Expression by Airway Clara Cells Independently of Th2 Responses
Dillard, P., Wetsel, R. A., & Drouin, S. M. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-049oc · Cited by 29
Bachmaier, K., Guzman, E., Kawamura, T., Gao, X., & Malik, A. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030742 · Cited by 29
Inflammatory mediators in the vitreous humor of AIDS patients with retinitis.
Mondino, B. J., Sidikaro, Y., Mayer, F. J., & Sumner, H. L. (1990) · PubMed · Cited by 28
Ratajczak, M. Z., Kim, C., Wu, W., Shin, D. M., Bryndza, E., Kucia, M., & Ratajczak, J. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_3 · Cited by 28
Regulation of Tissue Inflammation by Thrombin-Activatable Carboxypeptidase B (or TAFI)
Leung, L. L. K., Nishimura, T., & Myles, T. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_5 · Cited by 28
C5L2 – an Anti-inflammatory Molecule or a Receptor for Acylation Stimulating Protein (C3a-desArg)?
Johswich, K. O., & Klos, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-71767-8_12 · Cited by 27
Self-citationModeling Molecular Mechanisms of Binding of the Anaphylatoxin C5a to the C5a Receptor
Nikiforovich, G. V., Marshall, G. R., & Baranski, T. (2008) · Biochemistry · doi:10.1021/bi702321a · Cited by 27
Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists
Barbay, J. K., Gong, Y., Buntinx, M., Li, J., Claes, C., Hornby, P. J., Lommen, G. V., Wauwe, J. V., & He, W. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.049 · Cited by 27
Discovery of small molecule human C5a receptor antagonists
Sanganee, H. J., Baxter, A., Barber, S., Brown, A., Grice, D., Hunt, F., King, S. J., Laughton, D. L., Pairaudeau, G., Thong, B., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.104 · Cited by 27
Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis
Hoke, M., Speidl, W. S., Schillinger, M., Minar, E., Zehetmayer, S., Schönherr, M., Wagner, O. F., & Mannhalter, C. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02669.x · Cited by 26
Settmacher, B., Rheinheimer, C., Hamacher, H., Ames, R. S., Wise, A., Jenkinson, L., Bock, D., Schaefer, M., Köhl, J., & Klos, A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323293 · Cited by 26
Self-citationSuppression of food intake by a complement C3a agonist [Trp5]-oryzatensin(5–9)
Ohinata, K., Suetsugu, K., Fujiwara, Y., & Yoshikawa, M. (2007) · Peptides · doi:10.1016/j.peptides.2006.11.020 · Cited by 26
Cellular responses of guinea-pig macrophages to C4a; inhibition of C3a-induced O2− generation by C4a
Murakami, Y., Yamamoto, T., Imamichi, T., et al. (1993) · Immunology Letters · doi:10.1016/0165-2478(93)90104-a · Cited by 26
Sun, J., Ember, J. A., Chao, T., Hugli, T. E., Fukuoka, Y., & Ye, R. D. (1999) · Protein Science · doi:10.1110/ps.8.11.2304 · Cited by 26
Breivik, T. J., Gundersen, Y., Gjermo, P. E., Taylor, S. M., Woodruff, T. M., & Opstad, P. K. (2011) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2011.01383.x · Cited by 26
Gripentrog, J. M., & Miettinen, H. M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.11.002 · Cited by 25
Inactivation of the complement anaphylatoxin C5a by secreted products of parasitic nematodes
Rees-Roberts, D., Mullen, L., Gounaris, K., & Selkirk, M. E. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.10.006 · Cited by 25
The Transcription Factors AP-1 and Ets Are Regulators of C3a Receptor Expression
Schaefer, M., Konrad, S., Thalmann, J., Rheinheimer, C., Johswich, K. O., Sohns, B., & Klos, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508146200 · Cited by 25
Self-citationPotential Link Between C3a, C3b and Endothelial Progenitor Cells in Resistant Hypertension
Magen, E., Feldman, A., Mishal, J., Cohen, Z., Schlezinger, M., Alon, D. B., & Linov, L. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181d7d496 · Cited by 25
Hagemann, I. S., Miller, D. L., Klco, J. M., Nikiforovich, G. V., & Baranski, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709467200 · Cited by 25
Serum protein signature may improve detection of ductal carcinoma in situ of the breast
Solassol, J., Rouanet, P., Lamy, P., Allal, B., Favre, G., Maudelondé, T., & Mangé, A. (2009) · Oncogene · doi:10.1038/onc.2009.341 · Cited by 24
Cook, W. J., Galakatos, N. G., Boyar, W. C., Walter, R. L., & Ealick, S. E. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909049051 · Cited by 24
Hunt, J. R., Martin, C. B., & Martin, B. K. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.01.002 · Cited by 23
Lienenklaus, S., Ames, R. S., Tornetta, M. A., Sarau, H. M., Foley, J. J., Crass, T., Sohns, B., Raffetseder, U., Grove, M., Hölzer, A., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2089 · Cited by 23
Self-citationComplement Component 5a Receptor Oligomerization and Homologous Receptor Down-regulation
Rabiet, M., Huet, E., & Boulay, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805260200 · Cited by 22
Relationship between a Novel Polymorphism of the C5L2 Gene and Coronary Artery Disease
Zheng, Y., Xie, X., Ma, Y.-T., Yang, Y., Fu, Z.-Y., Li, X., Ma, X., Chen, B., & Liu, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020984 · Cited by 22
Food Intake Regulation by Central Complement System
Ohinata, K., & Yoshikawa, M. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_3 · Cited by 21
Increased Plasma Acylation‐Stimulating Protein Correlates with Hyperlipidemia at Late Gestation
Saleh, J., Cianflone, K., Chaudhary, T. A., Al‐Riyami, H. D. S., Al‐Abri, A., & Bayoumi, R. (2007) · Obesity · doi:10.1038/oby.2007.575 · Cited by 21
Governa, M., Fenoglio, I., Amati, M., Valentino, M., Bolognini, L., Coloccini, S., Volpe, A. R., Carmignani, M., & Fubini, B. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9351 · Cited by 21
Role of the carboxyl terminal di-leucine in phosphorylation and internalization of C5a receptor
Suvorova, E. S., Gripentrog, J. M., Oppermann, M., & Miettinen, H. M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.02.004 · Cited by 21
Nishiura, H., Tokita, K., Li, Y., Harada, K., Woodruff, T. M., Taylor, S. M., Nsiama, T. K., Nishino, N., & Yamamoto, T. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0511-y · Cited by 20
Lappas, M. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03336.x · Cited by 19
Morgan, M., Bulmer, A. C., Woodruff, T. M., Proctor, L. M., Williams, H. M., Stocks, S. Z., Pollitt, S., Taylor, S. M., & Shiels, I. A. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.01.009 · Cited by 19
Ohinata, K., Takagi, K., Biyajima, K., Kaneko, K., Miyamoto, C., Asakawa, A., Eguchi, N., Urade, Y., Inui, A., & Yoshikawa, M. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.09.001 · Cited by 19
Mueller‐Ortiz, S. L., Hollmann, T. J., Haviland, D. L., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00358.2005 · Cited by 19
Antimicrobial C3a –Biology, Biophysics, and Evolution
Malmsten, M., & Schmidtchen, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-71767-8_11 · Cited by 18
Mizutani, N., Goshima, H., Nabe, T., & Yoshino, S. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.10.010 · Cited by 18
A Comprehensive Structure-Function Map of the Intracellular Surface of the Human C5a Receptor
Matsumoto, M. L., Narzinski, K., Kiser, P. D., Nikiforovich, G. V., & Baranski, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607679200 · Cited by 18
Factor H binds to the N-terminus of adiponectin and modulates complement activation
Peake, P. W., & Shen, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.132 · Cited by 18
Hagemann, I. S., Narzinski, K., Floyd, D. H., & Baranski, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607686200 · Cited by 18
Mario Governa, M. A. (2000) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/009841000156664 · Cited by 18
Zheng, Y.-Y., Xie, X., Ma, Y., Yang, Y., Fu, Z.-Y., Li, X., Ma, X., Chen, B., & Liu, F. (2011) · Endocrine · doi:10.1007/s12020-011-9574-y · Cited by 17
Transcriptional control of the C3a receptor gene in glial cells: Dependence upon AP-1 but not Ets
Martin, C., Ingersoll, S. A., & Martin, B. K. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.04.017 · Cited by 17
Complement C5a receptors in the pituitary gland: expression and function
Francis, K. L., Lewis, B. M., Monk, P. N., & Ham, J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0110 · Cited by 17
Self-citationGoverna, M., Amati, M., Fenoglio, I., Valentino, M., Coloccini, S., Bolognini, L., Carlo Botta, G., Emanuelli, M., Pierella, F., Volpe, A. R., et al. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.019 · Cited by 16
Possible Role of Serum Anaphylatoxins in Hypersensitivity Reactions
Hugli, T. E., Stimler, N. P., Gerard, C. J., & Moon, K. E. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000232882 · Cited by 16
Cited by
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Neutrophil chemoattractant receptors in health and disease: Double-edged swords
Metzemaekers, M., Gouwy, M., & Proost, P. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0412-0 · Cited by 570
Complement component C3 – The “Swiss Army Knife” of innate immunity and host defense
Ricklin, D., Reis, E. S., Mastellos, D. C., Gros, P., & Lambris, J. D. (2016) · Immunological Reviews · doi:10.1111/imr.12500 · Cited by 484
New insights into the immune functions of complement
Reis, E. S., Mastellos, D. C., Hajishengallis, G., & Lambris, J. D. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0168-x · Cited by 470
Complement activation, regulation, and molecular basis for complement‐related diseases
Bajic, G., Degn, S. E., Thiel, S., & Andersen, G. R. (2015) · The EMBO Journal · doi:10.15252/embj.201591881 · Cited by 374
Metadata
- Authors
- Klos, A., Wende, E., Wareham, K. J., & Monk, P. N.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 65
- Issue
- 1
- Pages
- 500-543
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2126878361
- Cited by
- 264
- References
- 424
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.